Publications of Bernd Neumaier

Backes, H.; Ullrich, R.; Neumaier, B.; Kracht, L.; Wienhard, K.; Jacobs, A. H.: Non-invasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high grade glioma. European Journal of Nuclear Medicine and Molecular Imaging 36 (12), pp. 1960 - 1967 (2009)

Kobus, D.; Giesen, Y.; Neumaier, B.: A fully automated two-step synthesis of a 18F-labeled tyrosine kinase inhibitor for EGFR kinase activity imaging in tumors. Journal of Labelled Compounds and Radiopharmaceuticals 52 (Suppl. 1), p. S146 - S146 (2009)

Ullrich, R. T.; Zander, T.; Neumaier, B.; Koker, M.; Shimamura, T.; Waerzeggers, Y.; Borgman, C. L.; Tawadros, S.; Li, H.; Sos, M. L. et al.; Backes, H.; Shapiro, G. I.; Wolf, J.; Jacobs, A. H.; Thomas, R. K.; Winkeler, A.: Early detection of erlotinib treatment response in NSCLC by 3'-Deoxy-3'-[18F]-fluoro-L-thymidine ([18F]FLT) positron emission tomography (PET). PLoS ONE 3 (12), p. e3908 - e3908 (2008)

Ullrich, R.; Backes, H.; Li, H.; Kracht, L.; Miletic, H.; Kesper, K.; Neumaier, B.; Heiss, W.-D.; Wienhard, K.; Jacobs, A. H.: Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma. Clinical Cancer Research 14 (7), pp. 2049 - 2055 (2008)

Neumaier, B.; Deisenhofer, S.; Fürst, D.; Arnim, C.A.F. v.; Thees, S.; Buck, A.K.; Glatting, G.; Landwehrmeyer, G.B.; Krause, B.J.; Müller, H.D. et al.; Sommer, C.; Reske, S.N.; Mottaghy, F.M.: Radiosynthesis and evaluation of [11C]BTA-1 and [ 11C]3′-Me-BTA-1 as potential radiotracers for in vivo imaging of β-amyloid plaques. Nuklearmedizin 46 (6), pp. 271 - 280 (2007)

Neumaier, B.; Mottaghy, F.M.; Deisenhofer, S.; Arnim, C.A.F.v.; Fürst, D.; Thees, S.; Buck, A.K.; Glatting, G.; Landwehrmeyer, G.; Müller, H. et al.; Reske, S.N.: Radiosynthesis and evaluation of [N-methyl-11C]2-(4´-(methylamino)phenyl)-benzothiazole ([11C]BTA-1 and [N-methyl-11C]2-(3´-methyl-4´-(methylamino)phenyl)-benzothiazole ([11C]3´-Me-BTA-1 as potential radiotracers for in vivo imaging of amyloid plaques.